| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Australia | 1 | |
| #2 | Brazil | 1 | |
| #3 | Canada | 1 | |
| #4 | China | 1 | |
| #5 | EPO (European Patent Office) | 1 | |
| #6 | Israel | 1 | |
| #7 | Republic of Korea | 1 | |
| #8 | Singapore | 1 | |
| #9 | Taiwan | 1 | |
| #10 | United States | 1 | |
| #11 | WIPO (World Intellectual Property Organization) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Heterocyclic compounds | |
| #3 | Medical preparations |
| # | Name | Total Patents |
|---|---|---|
| #1 | Ciblat Stephane | 9 |
| #2 | Albert Vincent | 9 |
| #3 | Pal Kollol | 9 |
| #4 | Boudreault Jonathan | 9 |
| #5 | Bruneau-Latour Nicolas | 8 |
| #6 | Bruneau Latour Nicolas | 1 |
| #7 | Nicolas Bruneau-Latour | 1 |
| #8 | Jonathan Boudreault | 1 |
| #9 | Stephane Ciblat | 1 |
| #10 | Kollol Pal | 1 |
| Publication | Filing date | Title |
|---|---|---|
| US2021094956A1 | 5-(2,5-difluorophenyl)pyrrolidin-1-yl)-3-(1h-pyrazol-1-yl)pyrazolo[1,5-a]pyrimidine derivatives and related compounds as trk kinase inhibitors for treating cancer |